Douglas Braunstein and James Woolery

Published on October 10, 2018 at 11:49 am by Insider Monkey Staff in

Page 1 of 8

Douglas Braunstein‘s Hudson Executive Capital sold 205 thousand shares of Atricure Inc. (NASDAQ:ATRC) for more than $32.8 per share.

The details of the filing can be seen below:

Douglas Braunstein And James Woolery

Hudson Executive Capital

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Ownership Summary Table

Name	Shared Voting Power	Shared Dispositive Power	Aggregate Amount Owned Power	Percent of Class
Hudson Executive Capital	1,882,494	1,882,494	1,882,494	EXCLUDES CERTAIN SHARES 4.98%
HEC Management GP	1,882,494	1,882,494	1,882,494	EXCLUDES CERTAIN SHARES 4.98%
Douglas L. Braunstein	1,882,494	1,882,494	1,882,494	EXCLUDES CERTAIN SHARES 4.98%

Page 1 of 8 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 2)*

AtriCure, Inc.

(Name of Issuer)

Common Stock, par value $.001

(Title of Class of Securities)

04963C209

(CUSIP Number)

Michael D. Pinnisi
Hudson Executive Capital LP
570 Lexington Avenue
New York, NY 10022

with a copy to:
Richard M. Brand
Cadwalader, Wickersham & Taft, LLP

200 Liberty Street
New York, NY 10281

(212) 504-6000

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

October 5, 2018

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Atricure Inc. (NASDAQ:ATRC)Follow Atricure Inc. (NASDAQ:ATRC)

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 1 of 8

Next >>

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.

We may use your email to send marketing emails about our services. Click here to read our privacy policy.